Fomes fomentarius and Tricholoma anatolicum (Agaricomycetes) Extracts Exhibit Significant Multiple Drug-Resistant

Hasan Hüseyin Doğan1, Meltem Demirel Kars2, Özdem Özdemir1

  • 1Biology Department, Science Faculty, Selçuk University, Campus, Konya, Turkey.

Insights

Natural mushroom extracts from Fomes fomentarius and Tricholoma anatolicum show promise in overcoming multiple drug resistance (MDR) in breast cancer cells. These extracts may help reverse resistance to common chemotherapy drugs like paclitaxel and vincristine.

Area of Science:

  • Pharmacology
  • Natural Products Chemistry
  • Oncology

Background:

  • Multiple drug resistance (MDR) significantly limits the efficacy of cancer chemotherapy.
  • P-glycoprotein (P-gp) overexpression is a primary mechanism contributing to MDR in various cancers.
  • Natural compounds are being investigated for their potential to overcome MDR and enhance chemotherapeutic outcomes.

Purpose of the Study:

  • To evaluate the anticancer and MDR modulation activities of Fomes fomentarius and Tricholoma anatolicum extracts.
  • To assess the potential of these mushroom extracts in reversing P-glycoprotein-mediated drug resistance.
  • To identify phenolic compounds within the extracts that may contribute to their observed activities.

Main Methods:

  • Preparation of aqueous, methanol, and ethanol extracts from F. fomentarius and T. anatolicum.
  • Cytotoxicity assessment using the XTT assay on paclitaxel and vincristine-resistant MCF-7 cell lines (MCF-7/Pac and MCF-7/Vinc).
  • Flow cytometry analysis using Rhodamine 123 exclusion assay to determine P-glycoprotein reversing ability and MDR modulation effects.
  • High-Performance Liquid Chromatography (HPLC) for characterizing phenolic compounds.

Main Results:

  • The extracts exhibited cytotoxic effects against drug-resistant MCF-7 cell lines, with IC50 values ranging from 1.08 to 2.83 mg/mL.
  • Methanol extract of F. fomentarius and ethanol extract of T. anatolicum demonstrated significant potential as MDR reversing agents.
  • HPLC analysis identified 11 phenolic compounds in the tested extracts.

Conclusions:

  • Fomes fomentarius and Tricholoma anatolicum extracts possess cytotoxic and MDR-modulating properties against drug-resistant breast cancer cells.
  • Specific extracts, notably the methanol extract of F. fomentarius and ethanol extract of T. anatolicum, show promise for developing novel MDR reversal strategies.
  • Further research into these natural compounds could lead to improved therapeutic approaches for overcoming chemotherapy resistance in breast cancer.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
978
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K